Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Mitchell

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Annals of Thoracic Surgery|July 26, 2006
Effects of early steroid withdrawal after heart transplantationDavid H Rosenbaum, Brian C Adams, Joshua D Mitchell, et al.
Journal of the American College of Cardiology|May 13, 2022
Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years OldAamir Javaid, Zeina A Dardari, Joshua D Mitchell, et al.
JACC. Cardiooncology|October 4, 2021
Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology SocietyJoshua D Mitchell, Daniel A Cehic, Marita Morgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue SarcomaBrian A Van Tine, Angela C Hirbe, Peter Oppelt, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 15, 2026
Design and Rationale of the REVEAL PET Study: A Study of <sup>124</sup>I-evuzamitide to Diagnose Cardiac AmyloidosisSharmila Dorbala, Mathew S Maurer, Sarah A M Cuddy, et al.
Heart (British Cardiac Society)|January 24, 2024
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statementRichard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Annals of Thoracic Surgery|July 26, 2006
Effects of early steroid withdrawal after heart transplantationDavid H Rosenbaum, Brian C Adams, Joshua D Mitchell, et al.
Journal of the American College of Cardiology|May 13, 2022
Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years OldAamir Javaid, Zeina A Dardari, Joshua D Mitchell, et al.
JACC. Cardiooncology|October 4, 2021
Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology SocietyJoshua D Mitchell, Daniel A Cehic, Marita Morgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue SarcomaBrian A Van Tine, Angela C Hirbe, Peter Oppelt, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 15, 2026
Design and Rationale of the REVEAL PET Study: A Study of <sup>124</sup>I-evuzamitide to Diagnose Cardiac AmyloidosisSharmila Dorbala, Mathew S Maurer, Sarah A M Cuddy, et al.
Heart (British Cardiac Society)|January 24, 2024
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statementRichard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 9